<bill session="109" type="h" number="5993" updated="2014-12-10T13:45:27-05:00">
  <state datetime="2006-07-28">REFERRED</state>
  <status>
    <introduced datetime="2006-07-28"/>
  </status>
  <introduced datetime="2006-07-28"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.</title>
  </titles>
  <sponsor id="400121"/>
  <cosponsors>
    <cosponsor id="400026" joined="2006-07-28"/>
    <cosponsor id="400040" joined="2006-07-28"/>
    <cosponsor id="400282" joined="2006-07-28"/>
    <cosponsor id="400421" joined="2006-07-28"/>
  </cosponsors>
  <actions>
    <action datetime="2006-07-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2006-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="109" type="s" number="3695"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Generic drugs"/>
  </subjects>
  <amendments/>
  <summary>7/28/2006--Introduced.
Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.</summary>
</bill>
